January 16, 2026

Standard BioTools Inc. (LAB) Stock Analysis: Navigating a Challenging Market with Innovative Technologies

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector’s medical devices industry, is a company that demands the attention of savvy investors. With..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 751% Upside Potential in Biotech

Cel-Sci Corporation (NASDAQ: CVM) is capturing investor attention with its ambitious approach to cancer treatment and a staggering potential upside of 751.70%, according to analyst ratings...

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech with 94.53% Potential Upside

Rapport Therapeutics, Inc. (RAPP), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is making waves in the biotechnology sector with its promising pipeline focused on central..

Simulations Plus, Inc. (SLP) Stock Analysis: Is There a 15% Upside for This Healthcare Innovator?

Simulations Plus, Inc. (NASDAQ: SLP), a prominent player in the healthcare sector, is making waves with its cutting-edge drug discovery and development software. Renowned for its..

Oruka Therapeutics, Inc. (ORKA) Investor Outlook: Analyzing a 71% Potential Upside in Biotechnology

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is drawing significant attention from investors with its promising pipeline in the biotechnology sector. Specializing in the development of monoclonal antibody..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with Innovative Solutions in Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) stands at the intersection of innovation and challenge within the medical devices sector. With a focus on performance coating technologies for intravascular..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 75.60% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacture of medical instruments and supplies, particularly for treating peripheral..

LifeMD, Inc. (LFMD) Stock Analysis: A Potential Upside of 145% Amidst Growing Telehealth Demand

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is carving a niche in the rapidly expanding telehealth industry. With a market capitalization of..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Player with Over 100% Upside Potential

Precigen, Inc. (NASDAQ: PGEN) is garnering attention in the biotechnology sector with a striking potential upside of over 100%. As a discovery and clinical-stage biopharmaceutical company,..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Promising 119% Potential Upside in the Biotech Sector

Prothena Corporation plc (NASDAQ: PRTA), an Irish biotechnology firm, has captured the attention of investors with its robust product pipeline targeting diseases caused by protein dysregulation...

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unveiling a 276% Potential Upside in the Biotech Arena

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its potential upside of 276.13%. This..

Auna SA (AUNA) Stock Analysis: Exploring a 90.63% Potential Upside in Healthcare

Investors seeking opportunities in the healthcare sector might find Auna SA (AUNA) an intriguing prospect, as its current market dynamics present a significant potential upside. Operating..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A Promising Growth in Pediatric Orthopedics with 28.94% Potential Upside

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector, is carving a niche in the medical devices industry by focusing on pediatric orthopedics. Headquartered..

Semler Scientific, Inc. (SMLR) Stock Analysis: A Medical Device Innovator with 223% Potential Upside

Semler Scientific, Inc. (NASDAQ: SMLR), a player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors with its remarkable potential upside..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Navigating the Diagnostics Frontier with a Promising 12.88% Upside

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $1.19 billion,..

Organogenesis Holdings Inc. (ORGO) Stock Report: Analyzing a 114% Potential Upside in Regenerative Medicine

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, is drawing attention from investors with its significant potential upside of 114.11%. Specializing..

Septerna, Inc. (SEPN) Stock Report: Exploring a 21% Potential Upside Amidst Robust Growth Prospects

Septerna, Inc. (SEPN), a dynamic player in the biotechnology sector, is gaining attention from investors seeking high-growth opportunities in the healthcare industry. Founded in 2019 and..

Celcuity Inc. (CELC): Investment Insights on a Biotech Trailblazer with Strong Buy Ratings

For investors with a keen eye on the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents an intriguing opportunity. With a market capitalization of $4.87 billion, this..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring an 82% Potential Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is gaining attention in the biotech sector, not only because of its innovative approach to tackling cancer resistance mechanisms but also..

Verastem, Inc. (VSTM): Investor Outlook on Biotech’s 144% Potential Upside

Verastem, Inc. (NASDAQ: VSTM) has emerged as a biotech company capturing attention with its promising pipeline and significant upside potential. With its current market capitalization of..

Search

Funds

January 16, 2026

Search

Funds

January 16, 2026

FTSE 100

Funds